Growth factor regulation by tamoxifen is demonstrated in patients with breast cancer
Open Access
- 1 July 1993
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Mechanisms of normal and malignant breast epithelial growth regulationJournal of Steroid Biochemistry, 1989
- Epidermal and transforming growth factor α in patients with breast tumoursBritish Journal of Cancer, 1989
- Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol redThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth FactorScience, 1986
- Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture.Proceedings of the National Academy of Sciences, 1986
- Autocrine growth factors and cancerNature, 1985
- Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.Proceedings of the National Academy of Sciences, 1983
- Growth factors from murine sarcoma virus-transformed cells.Proceedings of the National Academy of Sciences, 1978
- Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorPublished by Elsevier ,1975